- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2022-002482-15.
Displaying page 1 of 1.
EudraCT Number: 2022-002482-15 | Sponsor Protocol Number: M23-696 | Start Date*: 2022-12-27 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG (AbbVie) | |||||||||||||
Full Title: A Phase 3b/4 Randomized, Open-label, Efficacy Assessor Blinded Study, Comparing the Safety and Assessor Blinded Efficacy of Upadacitinib to Dupilumab in Subjects with Moderate to Severe Atopic Derm... | |||||||||||||
Medical condition: Moderate to Severe Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) HU (Ongoing) SK (Completed) SE (Completed) FR (Completed) PL (Ongoing) IT (Ongoing) PT (Ongoing) DK (Completed) NL (Ongoing) GR (Ongoing) BE (Ongoing) BG (Ongoing) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.